tripalmitin has been researched along with paclitaxel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caputo, O; Cavalli, R; Gasco, MR | 1 |
| Arica-Yegin, B; Benoit, JP; Elkharraz, K; Faisant, N; Goepferich, A; Guse, C; Gust, R; Oger, JM; Siepmann, F; Siepmann, J | 1 |
| Baeyens, JM; Contreras-Cáceres, R; Leiva, MC; López-Romero, JM; Mayevych, I; Melguizo, C; Ortiz, R; Perazzoli, G; Prados, J; Sarabia, F | 1 |
3 other study(ies) available for tripalmitin and paclitaxel
| Article | Year |
|---|---|
Preparation and characterization of solid lipid nanospheres containing paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Drug Carriers; Half-Life; Paclitaxel; Phosphatidylcholines; Triglycerides | 2000 |
Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Drug Carriers; Drug Compounding; Drug Implants; Kinetics; Lactic Acid; Microspheres; Nikethamide; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Technology, Pharmaceutical; Triglycerides | 2006 |
Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Breast Neoplasms; Cell Line; Female; Humans; Lignans; Lung Neoplasms; MCF-7 Cells; Nanoparticles; Neoplastic Stem Cells; Paclitaxel; Polyethylene Glycols; Spheroids, Cellular; Triglycerides; Tumor Cells, Cultured | 2017 |